<p>A very special breed of animals is helping biotech and pharma companies in the quest for new human therapeutics. CFO Kurt Gustafson joins Pathfinders in Biopharma to explain the technologies behind OmniAb’s business model. </p>

A very special breed of animals is helping biotech and pharma companies in the quest for new human therapeutics. CFO Kurt Gustafson joins Pathfinders in Biopharma to explain the technologies behind OmniAb’s business model.

Shots-on-Goal Licensing Company Aims for Breakthroughs

Perspectives from the cutting edge of biotech and pharma.

The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series.

Lead today. Define tomorrow.

Business

News

Investing

Business News

Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.

Share Shots-on-Goal Licensing Company Aims for Breakthroughs

Sign up to save your podcasts

Shots-on-Goal Licensing Company Aims for Breakthroughs

Shots-on-Goal Licensing Company Aims for Breakthroughs

More shows like Pathfinders in Biopharma

Pardon My Take

The Daily

Up First from NPR

The Readout Loud

Making Sense

Biotech 2050 Podcast

Business Of Biotech

BioCentury This Week

RBC's Markets in Motion

Biotech Hangout

Industries in Motion

Powering Sustainable Ideas

Macro Minutes

Strategic Alternatives

Goldman Sachs The Markets

The BioCentury Show